H. TABAN Et Al. , "Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report," CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.8, 2022
TABAN, H. Et Al. 2022. Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report. CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.8 .
TABAN, H., GÜVEN, D. C., & Kilickap, S., (2022). Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report. CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.8.
TABAN, HAKAN, DENİZ CAN GÜVEN, And Saadettin Kilickap. "Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report," CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.8, 2022
TABAN, HAKAN Et Al. "Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report." CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.8, 2022
TABAN, H. GÜVEN, D. C. And Kilickap, S. (2022) . "Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report." CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.8.
@article{article, author={HAKAN TABAN Et Al. }, title={Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report}, journal={CUREUS JOURNAL OF MEDICAL SCIENCE}, year=2022}